Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Georgia

Memorial University Medical Center
Savannah Georgia 31404

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITD

View More ▼

Atlanta Georgia 30322

A clinical research study of CDX-301 with or without plerixafor

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Omacetaxine to evaluate Acute Myelogenous Leukemia (AML)

Illinois

Chicago Illinois 60637

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Indiana

Indianapolis Indiana 46237

A clinical research study of CDX-301 with or without plerixafor

Ohio

Columbus Ohio 43210

A clinical research study of CDX-301 with or without plerixafor

Virginia

Charlottesville Virginia 22908

A clinical research study of CDX-301 with or without plerixafor

Fairfax Virginia 22031

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Richmond Virginia 23298

A clinical research study of CDX-301 with or without plerixafor